If CYDY wants in, now is the time to release CD12 primary endpoint results.
If they are good, the mab on TV will be leronlimab.
Obviously, CYDY knows this.
Probably working very hard to pull the data release ahead on the news today.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-